Read Abraham’s full essay on her diagnosis and journey with colon cancer with interviews from other survivors, advocates, and clinicians, including Dr. John Marshall.

"Badge-up" with @marshalj23.bsky.social of @georgetownlombardi.bsky.social as he discusses #ASCO25 with @clinicalcaresol.bsky.social. Watch now: clinicalcaresolutions.net/activities/o...

After #ASCO25, stay up-to-date on the latest GI Cancer Research. View this week's tailored GI Cancer publication output via bit.ly/454GquF and sign up to have this weekly list delivered to your inbox: bit.ly/RueschWeeklyPub.

In this week's Ruesch Center GI Cancers publication search, @marshalj23.bsky.social highlighted research by Julien Taieb, Pierre Laurent-Puig, and others published in the Journal of Clinical Oncology. bit.ly/3Fkx2bI. Learn more: youtu.be/JlqL1f6vyak?...

View this week's tailored GI Cancer publication output via bit.ly/431rg6J. Sign up today to have this weekly list delivered to your inbox: bit.ly/RueschWeeklyPub. What research excited you this week?

This week, we highlighted research by Jill P Smith, Narayan Shivapurkar, Wenqiang Chen, Godhanjali Chekuri, Amani Dabney, Kyle Holmes, Hong Cao, Ruvanthi N Kularatne, and Stephan T Stern published in the Journal of Molecular Cancer Therapeutics. Learn more: bit.ly/4lTknwY

Save the Date for the 16th Annual Ruesch Center Symposium- Nov 21-22, 2025! @georgetownlombardi.bsky.social @marshalj23.bsky.social @onclive.bsky.social @medstarhealth.bsky.social

In an interview with Peers & Perspectives in Oncology, Dr. John Marshall discussed treatment approaches and sequencing for refractory colorectal cancer. www.targetedonc.com/view/managin...

Pancreatic Cancer 2025: After More Than 30 Years, Is That Light on the Horizon? @marshalj23.bsky.social shares insights in the Spring Issue of Oncolytics Today. Read the full article, pages 77-79-https://www.ncoda.org/news/oncolytics-today-spring-2025/

This week, we highlighted exciting research by Berend J van der Wilk, Ben M Eyck, Bas P L Wijnhoven, Sjoerd M Lagarde, J Jan B van Lanschot, and others published in @thelancetoncol.bsky.social. Learn more: bit.ly/3GkX52V.

@marshalj23.bsky.social and @marklewismd.bsky.social discuss how ctDNA clearance rates during and after adjuvant chemotherapy (ACT) in the BESPOKE trial provide critical insights into treatment efficacy and may serve as an early predictor of long-term patient outcomes. bit.ly/4luOsmd

Mass layoffs. Funding cuts. Uncertain futures. @marshalj23.bsky.social unpacks the turmoil hitting federal health agencies and what it means for researchers, clinical trials, and patient care. Who benefits from this chaos, and how can the medical community push back? bit.ly/42nXXLw

Targeted Therapy Options Sometimes Underutilized in Metastatic CRC. @marshalj23.bsky.social, discusses the sequencing of targeted therapy for refractory metastatic colorectal cancer. www.targetedonc.com/view/targete...

The Role of ctDNA in CRC. cancernetwork.com/view/the-rol... via @marshalj23.bsky.social @marklewismd.bsky.social

BESPOKE: Study Design, Efficacy End Points, and Methods. cancernetwork.com/view/bespoke... via @marshalj23.bsky.social @marklewismd.bsky.social

John L. Marshall, MD, discusses the impact of the SUNLIGHT trial in patients with refractory metastatic colorectal cancer. @marshalj23.bsky.social @georgetownlombardi.bsky.social www.targetedonc.com/view/sunligh...

The Ruesch team was thrilled to participate in this year’s #ScopeItOut and to support the work of the Colorectal Cancer Alliance in raising awareness about #ColorectalCancer.

“Pancreatic cancer has been the graveyard for drug discovery,” said Benjamin Weinberg, MD, a gastrointestinal medical oncologist at @georgetownlombardi.bsky.social. Researchers believe that could change with newer therapies, particularly those that target KRAS. www.wsj.com/health/healt...

🎉 Subscribe to #OncologyUnscripted for: ✨ Groundbreaking science & industry updates ✨ Expert interviews reshaping clinical practice ✨ A unique blend of facts, fun, & insight you won’t find anywhere else 👉 Subscribe today bit.ly/41vFVWW @clinicalcaresol.bsky.social

View this week's tailored GI Cancer publication output via bit.ly/4hoxqmx. What research was particularly interesting to you this week? Sign up today to have this weekly list delivered to your inbox: bit.ly/RueschWeeklyPub.

We were excited to join @fightcrc.bsky.social on the National Mall this evening to raise awareness about colorectal cancer at the United in Blue Rally. @georgetownlombardi.bsky.social #ColorectalCancerAwarenessMonth.

[email protected] reflects on the emotional toll of ongoing uncertainty in healthcare, particularly the impact on both providers and patients in the latest episode of #OncologyUnscripted. @clinicalcaresol.bsky.social bit.ly/3DxloJF

'Prof Rahul Roychoudhuri, from the University of Cambridge, said: "What we've discovered is that aspirin might work, surprisingly, by unleashing the power of the immune system to recognize and kill metastasizing cancer cells."' bbc.com/news/article...

"It's essential that we all do our part to increase awareness of colonoscopy guidelines and alternatives, so individuals can make informed decisions about their health and potentially save their lives," added Priyanka Kanth, MD @medstarhealth.bsky.social. www.prnewswire.com/news-release...

Dr Marshall highlights practice-changing research at ASCO GI (#GI25) and discusses the turmoil caused by the new presidential administration’s abrupt policy changes, which have disrupted federal health agencies, including the NIH and NCI. clinicalcaresolutions.net/activities/o...

Are you interested in support from a trained mentor as a GI cancer patient aged 18 to 49 or an Esophageal patient (any age) in the DMV area? For more information, contact Sarah Johnson at [email protected].

This week, we highlighted research by Pooja Mittal, Benjamin A Weinberg, @cancerassassin1.bsky.social, Anthony F Shields, Richard M Goldberg, @marshalj23.bsky.social , Sanjay Goel, Heinz-Josef Lenz, and others published in the International Journal of Cancer. Learn more: bit.ly/3QtcfF3

Learn about emerging therapies and evolving standards of care for patients with gastrointestinal (GI) cancer at the 10th Annual SOGO® on Saturday, Feb 15, 2025, in Pasadena, CA! Register using promo code "Marshall"-bit.ly/423XxLK @onclive.bsky.social

In a recent episode of Oncology Unscripted, John Marshall, MD, delves into the complex economics of cancer care in early 2025. As the new administration settles into Washington, D.C., Dr. Marshall explores the challenges and potential changes in the healthcare landscape.